Cochlear Limited (ASX:COH)
Australia · Delayed Price · Currency is AUD 280.00
-5.24 (-1.84%)
Sep 26, 2025, 4:10 PM AEST
Cochlear Market Cap
Cochlear has a market cap or net worth of 18.31 billion as of September 26, 2025. Its market cap has decreased by -3.61% in one year.
Market Cap
18.31B
Enterprise Value
18.27B
Revenue
2.34B
Ranking
n/a
PE Ratio
47.23
Stock Price
280.00
Market Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 44.18M to 18.31B, an increase of 41,348.35%. That is a compound annual growth rate of 22.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 18.31B | -3.45% |
| Dec 31, 2024 | 18.97B | -3.04% |
| Dec 29, 2023 | 19.56B | 45.68% |
| Dec 30, 2022 | 13.43B | -5.54% |
| Dec 31, 2021 | 14.22B | 14.41% |
| Dec 31, 2020 | 12.43B | -4.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 95.78B |
| Pro Medicus | 31.54B |
| Sonic Healthcare | 10.45B |
| Ramsay Health Care | 7.31B |
| Telix Pharmaceuticals | 5.03B |
| Ansell | 4.57B |
| Mesoblast | 3.19B |
| Neuren Pharmaceuticals | 2.45B |